Q4 2025 Holdings
Filed 2026-02-17 | 145 holdings | $388.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco DB Commdy Indx Trck(DBC) | UNIT | 46138B103 | $23.6M | 1,057,238 | 6.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $13.4M | 193,001 | 3.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.0M | 336,667 | 3.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.6M | 372,472 | 3.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.7M | 72,185 | 2.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $9.6M | 120,240 | 2.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.6M | 25,841 | 2.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $7.4M | 73,287 | 1.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.3M | 114,564 | 1.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $7.1M | 175,462 | 1.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $7.1M | 170,353 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.9M | 39,400 | 1.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $6.7M | 89,229 | 1.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.4M | 73,545 | 1.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.3M | 135,069 | 1.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $6.2M | 188,206 | 1.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.1M | 80,205 | 1.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $6.0M | 241,489 | 1.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.6M | 221,883 | 1.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $5.4M | 156,003 | 1.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.3M | 114,049 | 1.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $5.1M | 22,928 | 1.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $4.9M | 75,002 | 1.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $4.6M | 545,079 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $4.6M | 42,867 | 1.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.5M | 124,544 | 1.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $4.5M | 162,370 | 1.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $4.4M | 53,564 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.2M | 171,137 | 1.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.2M | 344,067 | 1.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $4.0M | 147,662 | 1.0% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $4.0M | 17,397 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $3.8M | 150,776 | 1.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $3.8M | 36,758 | 1.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.7M | 115,539 | 0.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $3.4M | 498,933 | 0.9% |
| Microsoft Corp(MSFT) | COM | 594918104 | $3.2M | 6,537 | 0.8% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $3.1M | 140,107 | 0.8% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $3.1M | 1,300,031 | 0.8% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $3.1M | 240,524 | 0.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.0M | 3,588 | 0.8% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $3.0M | 112,917 | 0.8% |
| Transdigm Group Inc(TDG) | COM | 893641100 | $2.9M | 2,175 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $2.9M | 40,020 | 0.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.9M | 238,812 | 0.7% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $2.9M | 229,263 | 0.7% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $2.7M | 14,220 | 0.7% |
| Salesforce Inc(CRM) | COM | 79466L302 | $2.3M | 8,613 | 0.6% |
| Visa Inc(V) | COM CL A | 92826C839 | $2.2M | 6,291 | 0.6% |
| Septerna Inc(SEPN) | COM | 81734D104 | $2.2M | 78,682 | 0.6% |